Cali Bio Announces Successful Hernia Phase 2 Results Publication
21 May 2024 //
PR NEWSWIRE
Cali Biosciences Initiates Second Phase III Study of CPL-01
05 Jun 2023 //
PR NEWSWIRE
Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine)
18 Apr 2023 //
PR NEWSWIRE